ЦЕРВИКАЛЬНАЯ ДИСТОНИЯ И КОМОРБИДНАЯ ПСИХИЧЕСКАЯ ПАТОЛОГИЯ: ОБЗОР ЛИТЕРАТУРЫ
М. А. Самушия
ФГБУ ДПО «Центральная государственная медицинская академия» УД Президента РФ, Москва
А. А. Рагимова
А. Ф. Иволгин
Т. Ю. Авсейцева
Е. А. Иванникова
С. М. Крыжановский

Ключевые слова

цервикальная дистония
тревога
депрессия
личность

Как цитировать

[1]
М. А. Самушия, А. А. Рагимова, А. Ф. Иволгин, Т. Ю. Авсейцева, Е. А. Иванникова, и С. М. Крыжановский, ЦЕРВИКАЛЬНАЯ ДИСТОНИЯ И КОМОРБИДНАЯ ПСИХИЧЕСКАЯ ПАТОЛОГИЯ: ОБЗОР ЛИТЕРАТУРЫ, КМКВ, вып. 4, сс. 105-119, дек. 2019.

Аннотация

Материалы и методы. На основе 123 зарубежных и отечественных работ был выполнен систематический обзор на тему генеза и клиники немоторных расстройств при цервикальной дистонии (ЦД) Основные выводы. ЦД является неврологическим заболеванием, имеющим нейрофизиологическое и генетическое обоснование. Отмечается высокая коморбидность ЦД к психическим расстройствам; ЦД имеет склонность к рецидивирующему течению; отмечается независимое течение моторных и немоторных составляющих заболевания. Для успешного лечения ЦД необходима комплексная терапия, направленная на лечение, как моторных, так и немоторных составляющих.

Литература

1. Defazio G, Abbruzzese G, Livrea P, Berardelli A. Epidemiology of Primary Dystonia. Lancet Neurol. 2004; 3(11): 673-678. doi:10.1016/s1474-4422(04)00907-x.
2. Tarsy D, David KS. Dystonia. N Engl. 2006; 355(8): 818-829. doi:10.1056/nejmra055549.
3. Steeves TD, Day L, Dykeman J, Jette N, Pringsheim T. The Prevalence of Primary Dystonia: A Systematic Review and Meta-Analysis. Movement Disorders. 2012; 27(14): 1789-1796. doi:10.1002/mds.25244.
4. Dauer W. Current Concepts on the Clinical Features, Aetiology and Management of Idiopathic Cervical Dystonia. Brain. 1998; 121(4): 547-560. doi:10.1093/brain/121.4.547.
5. Гусев Г.И., Гехт А.Б. Клинические рекомендации по диагностике и лечению дистонии. Всероссийское общество неврологов. 2014.
6. Stacy M. Idiopathic cervical dystonia: An overview. Neurology. 2000; 55: 2–8.
7. Bressman SB. Dystonia Update. Clin Neuropharmacol. 2000; 23(5): 239-251. doi:10.1097/00002826-200009000-00002.
8. Newby RE, Thorpe DE, Kempster PA, Alty JE. A History of Dystonia: Ancient to Modern. Mov Disord Clin Pract. 2017;4(4):478–485. doi:10.1002/mdc3.12493A History of Dystonia: Ancient to Modern. Mov Disord Clin Pract. 2017; 4(4): 478-485. doi:10.1002/mdc3.12493.
9. Tibbetts RW. Spasmodic Torticollis. J Psychosom Res. 1971; 15(4): 461- 469. doi:10.1016/0022-3999(71)90028-6.
10. Oppenheim H. Über eine eigenartige Krampfkrankheit des kindlichen und jugendlichen Alters (Dysbasia lordotica progressiva, Dystonia musculorum deformans). In Neurologisches Centralblatt; Veit: Leipzig. Germany, 1911; 30: 1090–1107. [Oppenheim H. About a strange convulsive illness of childhood and adolescence (Dysbasia lordotica progressiva, Dystonia musculorum deformans). In Neurologisches Centralblatt; Veit: Leipzig. Germany, 1911; 30: 1090–1107. In German]
11. Broussolle E, Laurencin C, Bernard E, Thobois S, Danaila T, Krack P. Early Illustrations of Geste Antagoniste in Cervical and Generalized Dystonia. Tremor Other Hyperkinet Mov. 2015;5:332. Published 2015 Sep 21. doi:10.7916/D8KD1X74
12. Cooper IS. Dystonia Musculorum Deformans: Natural History and Neurosurgical Alleviation.
J Pediatr. 1969; 74(4): 585-592. doi:10.1016/s0022-3476(69)80042-9.
13. Marsden CD. Blepharospasm-Oromandibular Dystonia Syndrome (Brueghels Syndrome). A Variant of Adult-Onset Torsion Dystonia? J Neurol Neurosurg Psychiatry. 1976; 39(12): 1204-1209. doi:10.1136/jnnp.39.12.1204.
14. Munts AG, Koehler PJ. How Psychogenic Is Dystonia? Views from Past to Present. Brain. 2010; 133(5): 1552-1564. doi:10.1093/brain/awq050.
15. Molho ES, Stacy M, Gillard P, Charles D, Adler C, Jankovic J et al. Impact of Cervical Dystonia on Work Productivity: An Analysis From a Patient Registry. Mov Disord Clin Pract. 2015; 3(2): 130-138. doi:10.1002/mdc3.12238.
16. Ortiz RM, Scheperjans F, Mertsalmi T, Pekkonen E. Comorbidity and retirement in cervical dystonia. J Neurol. 2019, 31. doi: 10.1007/s00415-019-09402-0.
17. Berman BD, Junker J, Shelton E, Sillau SH, Jinnah HA, Perlmutter JS et al. Psychiatric Associations of Adult-Onset Focal Dystonia Phenotypes. J Neurol Neurosurg Psychiatry. 2017; 88(7): 595-602. doi:10.1136/jnnp-2016-315461.
18. Mahajan A, Jankovic J, Marsh L, Patel A, Jinnah HA, Comella C et al. Cervical Dystonia and Substance Abuse. J Neurol. 2018; 265(4): 970-975. doi:10.1007/s00415-018-8840-9.
19. Yang J, Shao N, Song W, Wei Q, Ou R, Wu Y et al. Nonmotor Symptoms in Primary Adult-Onset Cervical Dystonia and Blepharospasm. Brain Behav. 2016; 7(2). doi:10.1002/brb3.592.
20. Gundel H. Social Phobia in Spasmodic Torticollis. J Neurol Neurosurg Psychiatry. 2001; 71(4): 499-504. doi:10.1136/jnnp.71.4.499.
21. Calheiros-Trigo F, Linhares P. Evaluation of the efficacy of deep brain stimulation in the surgical treatment of cervical dystonia. Neurocirugía. 2014; 25(2): 49-55. doi:10.1016/j.neucir.2013.10.004
22. Григорьева В.Н., Гузанова Е.В., Захарова Е.М. Возможности современных технологий нейровизуализации для нового понимания патогенеза цервикальной дистонии. Современные технологии в медицине. 2010; 1(1): 39-44.
23. Burke RE, Fahn S, Marsden CD, Bressman SB, Moskowitz C, Friedman J. Validity and Reliability of a Rating Scale for the Primary Torsion Dystonias. Neurology. 1985; 35(1): 73. doi:10.1212/wnl.35.1.73.
24. Smit M, Kuiper A, Han V, Jiawan VC, Douma G, van Harten B et al. Psychiatric Co-Morbidity Is Highly Prevalent in Idiopathic Cervical Dystonia and Significantly Influences Health-Related Quality of Life: Results of a Controlled Study. Parkinsonism Relat Disord. 2016; 30: 7–12. doi:10.1016/j.parkreldis.2016.06.004.
25. Ceylan D, Erer S, Zarifoğlu M, Türkeş N, Özkaya G. Evaluation of anxiety and depression scales and quality of LIFE in cervical dystonia patients on botulinum toxin therapy and their relatives. J Neurol Sci. 2019; 40(4): 725-731. doi:10.1007/s10072-019-3719-9.
26. Zoons E, Booij J, Speelman JD, Dreissen YEM, Smit M, Tijssen MAJ et al. Lower Serotonin Transporter Binding in Patients with Cervical Dystonia Is Associated with Psychiatric Symptoms. EJNMMI Research. 2017; 7(1). doi:10.1186/s13550-017-0338-4.
27. Matthews WB, Beasley P, Parry-Jones W, Garland G. Spasmodic torticollis: a combined clinical study. J Neurol Neurosurg Psychiatry 1978; 41:485–492.
28. Lencer R, Steinlechner S, Stahlberg J, Rehling H, Orth M, Baeumer T et al. Primary Focal Dystonia: Evidence for Distinct Neuropsychiatric and Personality Profiles. J Neurol Neurosurg Psychiatry. 2009; 80(10): 1176-1179. doi:10.1136/jnnp.2008.170191.
29. Bihari K, Hill JL, Murphy DL. Obsessive-Compulsive Characteristics in Patients with Idiopathic Spasmodic Torticollis. Psychiatry Res. 1992; 42(3): 267-272. doi:10.1016/0165-1781(92)90118-m.
30. Jahanshahi M, Marsden CD. Psychological Functioning before and after Treatment of Torticollis with Botulinum Toxin. J Neurol Neurosurg Psychiatry. 1992; 55(3): 229-231. doi:10.1136/jnnp.55.3.229.
31. Czekóová K, Zemánková P, Shaw DJ, Bareš M. Social Cognition and Idiopathic Isolated Cervical Dystonia. J Neural Transm. 2017; 124(9): 1097-1104. doi:10.1007/s00702-017-1725-8.
32. Antelmi E, Ferri R, Provini F, Scaglione CML, Mignani F, Rundo F et al. Modulation of the Muscle Activity During Sleep in Cervical Dystonia. Sleep. 2017; 40(7). doi:10.1093/sleep/zsx088.
33. Papathanasiou I, Donald L, Whurr R, Jahanshahi M. Perceived Stigma in Spasmoic Torticollis. Movement Disord. 2001; 16(2): 280-285. doi:10.1002/mds.1055.
34. Rinnerthaler M, Mueller J, Weichbold V, Wenning GK, Poewe W. Social Stigmatization in Patients with Cranial and Cervical Dystonia. Mov Disord. 2006; 21(10): 1636-1640. doi:10.1002/mds.21049.
35. Defazio G, Macerollo A. Epidemiology of Dystonia. Handbook of Dystonia. 2012; 2: 11–21. doi:10.3109/9781841848525.002.
36. Marras C, Van den Eeden SK, Fross RD, Benedict-Albers KS, Klingman J, Leimpeter AD et al. Minimum Incidence of Primary Cervical Dystonia in a Multiethnic Health Care Population. Neurology. 2007; 69(7): 676-680. doi:10.1212/01.wnl.0000267425.51598.c9.
37. Claypool D, Duane DD, Ilstrup DM, Melton LJ. Epidemiology and Outcome of Cervical Dystonia (Spasmodic Torticollis) in Rochester, Minnesota. Mov Disord. 1995; 10(5): 608–614. doi:10.1002/mds.870100513.
38. Xiao J, Uitti RJ, Zhao Y, Vemula SR, Perlmutter JS, Wszolek ZK et al. Mutations in CIZ1 Cause Adult Onset Primary Cervical Dystonia. Ann Neurol. 2012; 71(4): 458-469. doi:10.1002/ana.23547.
39. Warner T, Ben-Shlomo Y. Epidemiologic Study of Dystonia in Europe (ESDE) Collaborative Group. Sex-Related Influences on the Frequency and Age of Onset of Primary Dystonia. Neurology. 1999; 53(8): 1871. doi:10.1212/wnl.53.8.1871.
40. Zoons E. The role of dopamine and serotonin in cervical dystonia PhD thesis Faculty of Medicine (AMC-UvA). 2018
41. Краснов М.Ю., Тимербаева С.Л., Иллариошкин С.Н. Генетика наследственных форм дистонии. Анналы неврологии. 2013; 7(2): 55-62.
42. Zoons E, Tijssen MAJ. Pathologic Changes in the Brain in Cervical Dystonia Pre- and Post-Mortem — a Commentary with a Special Focus on the Cerebellum. Exp Neurol. 2013; 247: 130-133. doi:10.1016/j.expneurol.2013.04.005.
43. Fremont R, Tewari A, Angueyra C, Khodakhah K. A Role for Cerebellum in the Hereditary Dystonia DYT1. ELife. 2017; 6. doi:10.7554/elife.22775.
44. Fiorio M, Gambarin M, Valente EM, Liberini P, Loi M, Cossu G et al. Defective Temporal Processing of Sensory Stimuli in DYT1 Mutation Carriers: a New Endophenotype of Dystonia? Brain. 2006; 230(1): 134-142. doi:10.1093/brain/awl283.
45. Bradley D, Whelan R, Kimmich O, O'Riordan S, Mulrooney N, Brady P et al. Temporal Discrimination Thresholds in Adult-Onset Primary Torsion Dystonia: an Analysis by Task Type and by Dystonia Phenotype. J Neurol. 2011; 259(1): 77-8. doi:10.1007/s00415-011-6125-7.
46. Kägi G, Ruge D, Brugger F, Katschnig P, Sauter R, Fiorio M et al. Endophenotyping in Idiopathic Adult Onset Cervical Dystonia. Clin Neurophysiol. 2017; 128(7): 1142-1147. doi:10.1016/j.clinph.2017.04.007.
47. Obermann M, Yaldizli O, De Greiff A, Lachenmayer ML, Buhl AR, Tumczak F et al. Morphometric Changes of Sensorimotor Structures in Focal Dystonia. Mov Disord. 2007; 22(8): 1117-1123. vol. 22, no. 8, 2007, pp. 1117–1123., doi:10.1002/mds.21495.
48. Draganski B, Thun-Hohenstein C, Bogdahn U, Winkler J, May A. Motor Circuit Gray Matter Changes in Idiopathic Cervical Dystonia. Neurology. 2003; 61(9): 1228-1231. doi:10.1212/01.wnl.0000094240.93745.83.
49. Etgen T. Bilateral Grey-Matter Increase in the Putamen in Primary Blepharospasm. J Neurol Neurosurg Psychiatry. 2006; 77(9): 1017-1020. doi:10.1136/jnnp.2005.087148
50. Stamelou M, Edwards MJ, Hallett M, Bhatia KP. The Non-Motor Syndrome of Primary Dystonia: Clinical and Pathophysiological Implications. Brain. 2011; 135(6): 1668-1681. doi:10.1093/brain/awr224.
51. Zoons E, Booij J, Delnooz CCS, Dijk JM, Dreissen YEM, Koelman JHTM et al. Randomised Controlled Trial of Escitalopram for Cervical Dystonia with Dystonic Jerks/Tremor. J Neurol Neurosurg Psychiatry. 2018; 89(6): 579-585. doi:10.1136/jnnp-2017-317352.
52. Berardelli A. The Pathophysiology of Primary Dystonia. Brain. 1998; 121(7): 1195-1212. doi:10.1093/brain/121.7.1195.
53. Bologna M, Berardelli A. Cerebellum: An Explanation for Dystonia? Cerebellum Ataxias. 2017; 4(1). doi:10.1186/s40673-017-0064-8.
54. Raike RS Pizoli CE, Weisz C, van den Maagdenberg AM, Jinnah HA, Hess EJ. Limited Regional Cerebellar Dysfunction Induces Focal Dystonia in Mice. Neurobiol Dis. 2013; 49: 200-210. doi:10.1016/j.nbd.2012.07.019.
55. Batla A, Sánchez MC, Erro R, Ganos C, Stamelou M, Balint B et al. The Role of Cerebellum in Patients with Late Onset Cervical/Segmental Dystonia?–Evidence from the Clinic. Parkinsonism Relat Disord. 2015; 21(11): 1317-1322. doi:10.1016/j.parkreldis.2015.09.013.
56. Zoons E, Tijssen MAJ, Dreissen YEM, Speelman JD, Smit M, Booij J et al. The Relationship between the Dopaminergic System and Depressive Symptoms in Cervical Dystonia. Eur J Nucl Med Mol Imaging. 2017; 44(8): 1375-1382. doi:10.1007/s00259-017-3664-x.
57. Lee M-S, Anumagalla P, Talluri P, Pavuluri MN. Meta-Analyses of Developing Brain Function in High-Risk and Emerged Bipolar Disorder. Front Psychiatry. 2014; 5. doi:10.3389/fpsyt.2014.00141.
58. Aybek S, Nicholson TR, Zelaya F, O'Daly OG, Craig TJ, David AS et al. Neural Correlates of Recall of Life Events in Conversion Disorder. JAMA Psychiatry. 2014; 71(1): 52. doi:10.1001/jamapsychiatry.2013.2842.
59. Espay AJ, Maloney T, Vannest J, Norris MM, Eliassen JC, Neefus E et al. Dysfunction in Emotion Processing Underlies Functional (Psychogenic) Dystonia. Mov Disord. 2017; 33(1): 136-145. doi:10.1002/mds.27217.
60. Labate A, Cerasa A, Mula M, Mumoli L, Gioia MC, Aguglia U et al. Neuroanatomic Correlates of Psychogenic Nonepileptic Seizures: A Cortical Thickness and VBM Study. Epilepsia. 2011; 53(2): 377-385. doi:10.1111/j.1528-1167.2011.03347.x.
61. Nelson AJ, Blake DT, Chen R. Digit-Specific Aberrations in the Primary Somatosensory Cortex in Writers Cramp. Ann Neurol. 2009; 66(2): 146-154. doi:10.1002/ana.21626.
62. Scontrini A, Conte A, Fabbrini G, Colosimo C, Di Stasio F, Ferrazzano G et al. Somatosensory Temporal Discrimination Tested in Patients Receiving Botulinum Toxin Injection for Cervical Dystonia. Mov Disord. 2010; 26(4): 742-746. doi:10.1002/mds.23447.
63. Frima N, Nasir J, Grünewald RA. Abnormal Vibration-Induced Illusion of Movement in Idiopathic Focal Dystonia: An Endophenotypic Marker? Mov Disord. 2008; 23(3): 373-377. doi:10.1002/mds.21838.
64. Kägi G, Ruge D, Brugger F, Katschnig P, Sauter R, Fiorio M et al. Endophenotyping in Idiopathic Adult Onset Cervical Dystonia. Clin Neurophysiol. 2017; 128(7): 1142-1147. doi:10.1016/j.clinph.2017.04.007.
65. Schicatano EJ, Basso MA, Evinger C. Animal Model Explains the Origins of the Cranial Dystonia Benign Essential Blepharospasm. J Neurophysiol. 1997; 77(5): 2842-2846. doi:10.1152/jn.1997.77.5.2842
66. Nevrlý M, Hluštík P, Hok P, Otruba P, Tüdös Z, Kaňovský P. Changes in Sensorimotor Network Activation after Botulinum Toxin Type A Injections in Patients with Cervical Dystonia: a Functional MRI Study. Exp Brain Res. 2018; 236(10): 2627-2637. doi:10.1007/s00221-018-5322-3.
67. Thayer ZC, Johnson BW, Corballis MC, Hamm JP. Perceptual and Motor Mechanisms for Mental Rotation of Human Hands. Neuroreport. 2001; 12(16): 3433-3437. doi:10.1097/00001756-200111160-00011.
68. Bhidayasiri R, Daniel DT. Dystonic Body Perception in Childhood Dystonia. Clin Neurol Neurosurg. 2007; 109(5): 446-447. doi:10.1016/j.clineuro.2007.02.005.
69. Волкова С.А., Cкоромец А.А. Нейродинамика зрительных процессов в передних отделах мозга при правосторонней цервикальной дистонии. Ученые записки СпбГМУ им. Акад. И. П. Павлова. 2010; 17(1).
70. Eddy CM, Hugh ER. Theory of Mind Can Be Impaired Prior to Motor Onset in Huntington’s Disease. Neuropsychology. 2015; 29(5): 792-798. doi:10.1037/neu0000190.
71. Gregory C, Lough S, Stone V, Erzinclioglu S, Martin L, Baron-Cohen S et al. Theory of Mind in Patients with Frontal Variant Frontotemporal Dementia and Alzheimer’s Disease: Theoretical and Practical Implications. Brain. 2002; 125(4): 752-764. doi:10.1093/brain/awf079
72. Baron-Cohen S, Leslie AM, Frith U. Does the Autistic Child Have a ‘Theory of Mind? Cognition. 1985; 21(1): 37-46. doi:10.1016/0010-0277(85)90022-8.
73. Bora E, Walterfang M, Velakoulis D. Theory of Mind in Parkinson’s Disease: A Meta-Analysis. Behav Brain Res. 2015; 292: 515-520. doi:10.1016/j.bbr.2015.07.012.
74. Dool JVD, Tijssen MA, Koelman JH, Engelbert RH, Visser B. Determinants of Disability in Cervical Dystonia. Parkinsonism Relat Disord. 2016; 32: 48-53. doi:10.1016/j.parkreldis.2016.08.014.
75. Berardelli I, Pasquini M, Conte A, Bologna M, Berardelli A, Fabbrini G. Treatment of Psychiatric Disturbances in Common Hyperkinetic Movement Disorders. Expert Rev Neurother. 2018; 19(1): 55-65. doi:10.1080/14737175.2019.1555475.
76. Сагалакова О.А., Труевцев Д.В., Стоянова И.Я. Синдром социальной фобии и его психологическое содержание. Журнал неврологии и психиатрии им. С.С. Корсакова. 2017; 117(4): 15-22.
77. Jahanshahi M, Marsden CD. Conversion "v" profiles in torticollis. Behav Neurol. 1989; 2(4): 219-25. doi: 10.3233/BEN-1989-2403.
78. Jahanshahi M, Marion MH, Marsden CD. Natural History of Adult-Onset Idiopathic Torticollis. Arch Neurol. 1990; 47(5): 548-552. doi:10.1001/archneur.1990.00530050070014.
79. Robertson MM, Trimble MR. Some Personality Variables in Functional Neurological Disorders. Behav Neurol. 1988; 1(1): 23-28. doi:10.1155/1988/839812.
80. Naber D, Weinberger DR, Bullinger M, Polsby M, Chase TN. Personality Variables, Neurological and Psychopathological Symptoms in Patients Suffering from Spasmodic Torticollis. Compr Psychiatry. 1988; 29(2): 1822-187. doi:10.1016/0010-440x(88)90012-0.
81. Авсейцева Т.Ю., Иволгин А.Ф. Немоторные симптомы цервикальной дистонии. Вестник Российской военно-медицинской академии. 2018; 3(63).
82. Лихачев С.А., Чернуха Т.Н. Боль в клинической картине спастической кривошеи: клинико-нейрофизиологические сопоставления. Российский журнал боли. 2015; 4(3).
83. Morgante F, Matinella A, Andrenelli E, Ricciardi L, Allegra C, Terranova C et al. Pain Processing in Functional and Idiopathic Dystonia: An Exploratory Study. Movement Disord. 2018; 33(8): 1340-1348. doi:10.1002/mds.27402.
84. Camargo C, Cattai L, Teive HA. Pain Relief in Cervical Dystonia with Botulinum Toxin Treatment. Toxins. 2015; 7(6): 2321-2335. doi:10.3390/toxins7062321.
85. Faircloth S Reid S. A Cognitive–Behavioural Approach to the Management of Idiopathic Cervical Dystonia. J Behav Ther Exp Psychiatry. 2006; 37(3): 239-246. doi:10.1016/j.jbtep.2005.07.003.
86. Castelão M, Marques RE, Duarte GS, Rodrigues FB, Ferreira J, Sampaio C et al. Botulinum Toxin Type A Therapy for Cervical Dystonia. Cochrane Database Syst Rev. 2017. doi:10.1002/14651858.cd003633.pub3.
87. Dressler D, Bigalke H. Botulinum Toxin Type B De Novo Therapy of Cervical Dystonia. J Neurol. 2005; 252(8): 904-907. doi:10.1007/s00415-005-0774-3.
88. Marques RE, Duarte GS, Rodrigues FB, Castelão M, Ferreira J, Sampaio C et al. Botulinum Toxin Type B for Cervical Dystonia. Cochrane Database Syst Rev. 2016.doi:10.1002/14651858.cd004315.pub3.
89. Duarte GS, Castelão M, Rodrigues FB, Marques RE, Ferreira J, Sampaio C et al. Botulinum Toxin Type A versus Botulinum Toxin Type B for Cervical Dystonia. Cochrane Database Syst Rev. 2016. doi:10.1002/14651858.cd004314.pub3.
90. Duarte GS, Castelão M, Rodrigues FB, Marques RE, Ferreira J, Sampaio C et al. Deep Brain Stimulation for Dystonia. Cochrane Database of Systematic Reviews. 2016. doi:10.1002/14651858.cd012405.
91. Cardoso F. Toxina Botunílica Tipo B No Manejo De Distonia Não-Responsiva a Toxina Botunílica Tipo A. Arq Psiquiatr. 2003; 61(3): 607-610. doi:10.1590/s0004-282x2003000400015.
92. Comella CL, Jankovic J, Shannon KM, Tsui J, Swenson M, Leurgans S et al. Comparison of Botulinum Toxin Serotypes A and B for the Treatment of Cervical Dystonia. Neurology. 2005; 65(9): 1423-1429. doi:10.1212/01.wnl.0000183055.81056.5c.
93. De Pauw J, van der Velden K, Meirte J, van Daele U, Truijen S, Cras P et al. The effectiveness of physiotherapy for cervical dystonia: A systematic literature review. J Neurol. 2014; 261: 1857–1865.
94. Семенова О.В., Тимербаева С.Л., Коновалов Р.Н. Возможности метода функциональной магнитно- резонансной томографии покоя в изучении патофизиологии первичной фокальной дистонии. Анналы неврологии. 2017; 11(2): 44-50.
95. Limousin-Dowsey P, Pollak P, Van Blercom N, Krack P, Benazzouz A, Benabid A. Thalamic, Subthalamic Nucleus and Internal Pallidum Stimulation in Parkinsons Disease. J Neurol. 1999; 246(2): 42-45. doi:10.1007/pl00007750.
96. Kupsch A, Benecke R, Müller J, Trottenberg T, Schneider GH, Poewe W et al. Pallidal Deep-Brain Stimulation in Primary Generalized or Segmental Dystonia. N Engl J Med. 2006; 355(19): 1978-1990. doi:10.1056/nejmoa063618.
97. Rodrigues FB, Duarte GS, Prescott D, Ferreira J, Costa J et al. Deep Brain Stimulation for Dystonia. Cochrane Database of Systematic Reviews. 2019, doi:10.1002/14651858.cd012405.pub2.
98. Weaver FM. Bilateral Deep Brain Stimulation vs Best Medical Therapy for Patients With Advanced Parkinson DiseaseA Randomized Controlled Trial. Jama. 2009; 301(1): 63. doi:10.1001/jama.2008.929.
99. Greene P, Shale H, Fahn S. Analysis of Open-Label Trials in Torsion Dystonia Using High Dosages of Anticholinergics and Other Drugs. Movement Disord. 1988; 3(1): 46-60. doi:10.1002/mds.870030107.
100. Foncke EMJ, Schuurman PR, Speelman JD. Suicide after Deep Brain Stimulation of the Internal Globus Pallidus for Dystonia. Neurology. 2006; 66(1): 142-143.
101. Houser MK, Soland VL, Bhatia KP, Quinn NP, Marsden CD. Paroxysmal Kinesigenic Choreoathetosis: a Report of 26 Patients. J Neurol. 1999; 246(2): 120-126. doi:10.1007/s004150050318.
102. Nutt JG, Torbjoern GN. Response to Levodopa Treatment in Dopa-Responsive Dystonia. Arch Neurol. 2001; 58(6): 905. doi:10.1001/archneur.58.6.905.
103. Albanese A, Barnes MP, Bhatia KP, Fernandez-Alvarez E, Filippini G, Gasser T et al. A Systematic Review on the Diagnosis and Treatment of Primary (Idiopathic) Dystonia and Dystonia plus Syndromes: Report of an EFNS/MDS-ES Task Force. Eur J Neurol.. 2006; 13(5): 433-444. doi:10.1111/j.1468-1331.2006.01537.x.
104. Burke RE, Fahn S, Marsden CD. Torsion Dystonia: A Double-Blind, Prospective Trial of High-Dosage Trihexyphenidyl. Neurology. 1986; 36(2): 160. doi:10.1212/wnl.36.2.160.
105. Pisani A, Bernardi G, Ding J, Surmeier DJ. Re-Emergence of Striatal Cholinergic Interneurons in Movement Disorders. Trends Neurosci. 2007; 30(10): 545-553. doi:10.1016/j.tins.2007.07.008.
106. Strzelczyk A, Bürk K, Oertel WH. Treatment of Paroxysmal Dyskinesias. Expert Opin Pharmacother. 2010; 12(1): 63-72. doi:10.1517/14656566.2010.513971.
107. Jankovic J. Medical therapy and botulinum toxin in dystonia. Adv Neurol. 1998; 78: 169–83.
108. Fasano A, Bove F, Lang AE. The Treatment of Dystonic Tremor: a Systematic Review. J Neurol Neurosurg Psychiatry. 2013; 85(7): 759-769. doi:10.1136/jnnp-2013-305532.
109. Brennan MJ, Ruff P, Sandyk R. Efficacy of a Combination of Sodium Valproate and Baclofen in Meiges Disease (Idiopathic Orofacial Dystonia). BMJ. 1982; 285(6345): 853. doi:10.1136/bmj.285.6345.853.
110. Richardson SP, Tinaz S, Chen R. Repetitive Transcranial Magnetic Stimulation in Cervical Dystonia: Effect of Site and Repetition in a Randomized Pilot Trial. Plos One. 2015; 10(4). doi:10.1371/journal.pone.0124937.
111. Tso G, Uday K. Quetiapine-Induced Cervical Dystonia.” Australas Psychiatry. 2015; 26(3): 311-312. doi:10.1177/1039856215618526.
112. Gupta B, Ahmad J, Kar S, Shrivastava A. Sertraline Induced Cervical Dystonia in a Patient of Obsessive Compulsive Disorder. Asian J Psychiatr. 2018; 31: 77-78. doi:10.1016/j.ajp.2018.01.018.
113. Ittasakul P, Srivastava S, Hiranyatheb T, Ketter TA. Torticollis after Low-Dose Aripiprazole Administration in a Thai Schizophrenia Patient. Asian J Psychiatr. 2012; 5(4): 365-366. doi:10.1016/j.ajp.2012.02.002.
114. Berardelli I, Ferrazzano G, Pasquini M, Biondi M, Berardelli A, Fabbrini G. Clinical Course of Psychiatric Disorders in Patients with Cervical Dystonia. Psychiatry Res. 2015; 229(1-2): 583-585. doi:10.1016/j.psychres.2015.07.076.
115. Bernstein CJ, Ellard DR, Davies G, Hertenstein E, Tang NK, Underwood M et al. Behavioural Interventions for People Living with Adult-Onset Primary Dystonia: a Systematic Review. BMC Neurology. 2016; 16(1): 40-45 doi:10.1186/s12883-016-0562-y.
116. Львова О.А., Гужина Е.Ю. К вопросу о комплексном подходе к лечению цервикальной дистонии. Неврология. 2016; 137(4).
117. Толмачева В.А., Нодель М.Р., Салоухина Н.И. Недвигательные нарушения при цервикальной дистонии. Неврология, нейропсихиатрия, психосоматика. 2018; 10(3): 135–140.
118. Defazio G, Conte A, Gigante AF, Fabbrini G, Berardelli A. Is Tremor in Dystonia a Phenotypic Feature of Dystonia? Neurology. 2015; 84(10): 1053-1059. doi:10.1212/wnl.0000000000001341.
119. Hertenstein E, Tang NK, Bernstein CJ, Nissen C, Underwood MR, Sandhu HK. Sleep in Patients with Primary Dystonia: A Systematic Review on the State of Research and Perspectives. Sleep Med Rev. 2016; 26: 95-107. doi:10.1016/j.smrv.2015.04.004.
120. Hwang WJ, Calne DB, Tsui JK, de la Fuente-Fernández R. The Long-Term Response to Levodopa in Dopa-Responsive Dystonia. Parkinsonism Relat Disord. 2001; 8(1): 1-5. doi:10.1016/s1353-8020(00)00084-5.
121. Jain S, Lo SE, Louis ED. Common Misdiagnosis of a Common Neurological Disorder. Arch Neurol. 2006; 63(8): 1100. doi:10.1001/archneur.63.8.1100.
122. Kaji R, Rothwell JC, Katayama M, Ikeda T, Kubori T, Kohara N et al. Tonic Vibration Reflex and Muscle Afferent Block in Writers Cramp. Ann Neurol. 1995; 38(2): 155-162. doi:10.1002/ana.410380206.
123. Stein MB, Heuser IJ, Juncos JL, Uhde TW. Anxiety disorders in patients with Parkinson’s disease. Am J Psychiatry 1990; 147:217–220. doi: 10.1176/ajp.147.2.217